95 related articles for article (PubMed ID: 22778319)
1. Polyclonal serum free light chains: a biomarker of disease prognosis or of immune senescence?
Bibas M
J Clin Oncol; 2012 Aug; 30(24):3033-4; author reply 3034. PubMed ID: 22778319
[No Abstract] [Full Text] [Related]
2. Polyclonal immunoglobulin free light chain levels predict survival in myeloid neoplasms.
Pardanani A; Lasho TL; Finke CM; Rajkumar SV; Singh PP; Ketterling RP; Hanson CA; Katzmann JA; Tefferi A
J Clin Oncol; 2012 Apr; 30(10):1087-94. PubMed ID: 22331938
[TBL] [Abstract][Full Text] [Related]
3. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain κ and λ to polyclonal antibody-based assays and immunofixation electrophoresis.
Drayson M; Carr-Smith H
Clin Chem Lab Med; 2012 Mar; 50(3):587-8. PubMed ID: 22505553
[No Abstract] [Full Text] [Related]
4. Risk of antigen excess in serum free light chain measurements.
Daval S; Tridon A; Mazeron N; Ristori JM; Evrard B
Clin Chem; 2007 Nov; 53(11):1985-6. PubMed ID: 17954504
[No Abstract] [Full Text] [Related]
5. Biological variation of free light chains in serum.
Braga F; Infusino I; Dolci A; Panteghini M
Clin Chim Acta; 2013 Jan; 415():10-1. PubMed ID: 22981867
[No Abstract] [Full Text] [Related]
6. Critical evaluation of the serum kappa/lambda light-chain ratio in the detection of M proteins.
Laine ST; Soppi ET; Mörsky PJ
Clin Chim Acta; 1992 Apr; 207(1-2):143-9. PubMed ID: 1591862
[No Abstract] [Full Text] [Related]
7. Pediatric and perinatal reference intervals for immunoglobulin light chains kappa and lambda.
Herkner KR; Salzer H; Böck A; Mühl A; Tsaka T; Steger H; Pollak A; Schatten C; Popp W; Huber-Spitzy V
Clin Chem; 1992 Apr; 38(4):548-50. PubMed ID: 1568320
[TBL] [Abstract][Full Text] [Related]
8. Analytical performance of the serum free light chain assay.
Briand PY; Decaux O; Caillon H; Grosbois B; Le Treut A; Guenet L
Clin Chem Lab Med; 2010; 48(1):73-9. PubMed ID: 19929752
[TBL] [Abstract][Full Text] [Related]
9. Quantification of serum free light chain kappa and lambda by the SPAPLUS analyser.
Maisin D; Lepoutre T; Gruson D; Wallemacq P
Clin Biochem; 2013 May; 46(7-8):622-6. PubMed ID: 23291296
[TBL] [Abstract][Full Text] [Related]
10. Serum free light chain analysis.
Davids MS; Murali MR; Kuter DJ
Am J Hematol; 2010 Oct; 85(10):787-90. PubMed ID: 20721885
[TBL] [Abstract][Full Text] [Related]
11. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.
Akar H; Seldin DC; Magnani B; O'Hara C; Berk JL; Schoonmaker C; Cabral H; Dember LM; Sanchorawala V; Connors LH; Falk RH; Skinner M
Amyloid; 2005 Dec; 12(4):210-5. PubMed ID: 16399645
[TBL] [Abstract][Full Text] [Related]
12. A multicentre study comparing two methods for serum free light chain analysis.
Lock RJ; Saleem R; Roberts EG; Wallage MJ; Pesce TJ; Rowbottom A; Cooper SJ; McEvoy ED; Taylor JL; Basu S
Ann Clin Biochem; 2013 May; 50(Pt 3):255-61. PubMed ID: 23605135
[TBL] [Abstract][Full Text] [Related]
13. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.
Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H
Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433
[TBL] [Abstract][Full Text] [Related]
14. Kappa/lambda ratio as parameter for evaluation of therapy-resistant epilepsy of childhood.
Lischka A; Graf M; Hauser E; Herkner KR
Eur Neurol; 1994; 34 Suppl 1():74-8. PubMed ID: 8001615
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.
Hutchison CA; Harding S; Hewins P; Mead GP; Townsend J; Bradwell AR; Cockwell P
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1684-90. PubMed ID: 18945993
[TBL] [Abstract][Full Text] [Related]
16. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis.
Jaskowski TD; Litwin CM; Hill HR
Clin Vaccine Immunol; 2006 Feb; 13(2):277-80. PubMed ID: 16467338
[TBL] [Abstract][Full Text] [Related]
17. Judging disease activity in rheumatoid arthritis by serum free kappa and lambda light chain levels.
Ye Y; Li SL; Xie M; Jiang P; Liu KG; Li YJ
Kaohsiung J Med Sci; 2013 Oct; 29(10):547-53. PubMed ID: 24099109
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
[TBL] [Abstract][Full Text] [Related]
19. Higher serum levels of free ĸ plus λ immunoglobulin light chains ameliorate survival of hemodialysis patients.
Thilo F; Caspari C; Scholze A; Tepel M
Kidney Blood Press Res; 2011; 34(5):344-9. PubMed ID: 21646814
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting.
Zeman D; Kušnierová P; Švagera Z; Všianský F; Byrtusová M; Hradílek P; Kurková B; Zapletalová O; Bartoš V
PLoS One; 2016; 11(11):e0166556. PubMed ID: 27846293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
